查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1462651

全球减重和肥胖管理市场预测（截至 2030 年）：按产品类型、年龄层、设备、服务、分销管道、最终用户和地区进行分析

Weight Loss and Obesity Management Market Forecasts to 2030 - Global Analysis By Product Type, Age Group, Equipment, Service, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

2023年全球减重及肥胖管理市场规模为2,829亿美元，预估至2030年将达5,549亿美元，预测期内复合年增长率为10.1%。帮助肥胖和超重人群减重或维持体重的技术和药物包含在减重和肥胖管理市场中。

基本上，肥胖是一种长期的健康状况，其特征是体内脂肪异常沉积和累积。 BMI（身体质量指数）用于计算肥胖程度。用于减重和对抗肥胖的方法包括药物、运动、营养补充和减重手术。

健康政策组织美国健康信託基金2021年发布的报告发现，美国肥胖危机已波及19个州，肥胖率超过35%。

肥胖率增加

由于久坐的生活方式、不健康的饮食习惯以及促进体重增加的环境因素的蔓延，肥胖流行已达到惊人的水平。人们越来越认识到与肥胖相关的健康风险，例如心血管疾病、糖尿病和某些癌症，这增加了对有效体重管理解决方案的需求。这种需求正在推动各种干预措施的开发和采用，从生活方式改变计划到药物和外科手术。

成本高

与减重计画相关的费用，如药物、手术、咨询和特殊饮食，可能会成为个人寻求帮助的障碍，特别是那些低收入和没有足够健康保险的人。这些干预措施的经济负担常常阻碍人们寻求专业协助或遵循规定的治疗计划。然而，缺乏全面的减重服务保险使问题变得更加复杂，使许多人无法负担必要的治疗。结果是，获得治疗的机会差距不断扩大，肥胖相关健康结果的不平等现象长期存在。

技术进步

创新技术正在提供从穿戴式健身追踪器和行动应用程式到先进手术技术和药物干预的解决方案。这些进步使得能够满足个人需求和偏好的有针对性的、个人化的减重和肥胖管理策略成为可能。数位健康平台提供即时监控、资料分析和行为跟踪，帮助个人就其健康和生活方式选择做出明智的决定。

缺乏有效的长期解决方案

儘管有许多减重干预措施，但随着时间的推移持续减重对许多人来说仍然是一个挑战。流行的饮食、补充品和临时生活方式的改变通常会产生初步效果，但效果往往是短暂的。缺乏持续影响会削弱消费者信心并阻碍市场成长。此外，肥胖是一种复杂的疾病，其原因有很多，包括遗传、环境和行为因素，因此很难发展出普遍有效的治疗方法。

COVID-19 的影响：

封锁、行动限制和社交距离措施扰乱了世界各地人们的日常生活，减少了体力活动，并增加了久坐行为。压力、焦虑和不确定性进一步导致了许多人不健康的饮食习惯和体重增加。相反，有些人利用这次大流行作为优先考虑健康并专注于减重目标的机会。远端医疗和虚拟就诊越来越受欢迎，允许远端存取医疗保健专业人员和体重管理计划。

预计健身器材领域在预测期内将是最大的

预计健身器材领域在预测期内将占据最大份额。人们对肥胖相关健康风险的认识不断提高，对方便有效的体重管理方法的需求也随之增加。跑步机、文具自行车、椭圆机和举重机等健身设备为使用者提供了多种选择，可根据他们的喜好和能力进行身体活动。健身器材的这种便利性和多功能性使人们能够积极主动地实现个人减重目标，从而推动市场成长。

预计瘦身中心细分市场在预测期内复合年增长率最高

瘦身中心部门预计将在预测期内实现盈利增长，因为它提供针对个人需求的个人化和全面的计划，包括饮食计划、运动习惯和医疗监督。随着健康和健身意识的增强以及肥胖盛行率的不断增加，越来越多的人开始向瘦身中心寻求专业指导和支持，以实现减重目标。

比最大的地区

预计亚太地区将在整个预测期内占据最大的市场份额。随着人们对肥胖对健康的负面影响的认识不断增强，人们正在寻求适合其特定需求和情况的客製化解决方案。个人化的医疗方法，例如基因检测、客製化饮食计划和有针对性的运动方案，正在取得进展，因为它们比一般治疗方法更有效、更永续。此外，穿戴式健身设备和行动健康应用程式使个人能够监控自己的进展并就其健康之旅做出明智的决定。

复合年增长率最高的地区：

预计欧洲在预测期内将保持良好的成长。随着这些地区的人们达到更高的收入水平，他们倾向于优先考虑健康和保健，包括体重管理和肥胖预防。这种需求激增对欧洲减重和肥胖管理产品和服务市场产生了重大影响。该行业的欧洲公司正在充分利用这一机会，扩大其业务和分销网络，以满足开发中国家日益增长的需求。因此，这些因素正在推动该地区的成长。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球减重与肥胖管理市场：依产品类型

  • 药品
    • 伴随药物
    • 血清素受体促效剂
    • 脂肪酶抑制剂
    • GLP-1受体促效剂
    • 中枢促效剂
    • 其他药品
  • 装置
    • 胃电刺激系统
    • 排放系统
    • 胃内球囊系统
    • 胃束带
    • 减肥吻合器装置
    • 其他设备
  • 其他产品类型

第六章 全球减重与肥胖管理市场：依年龄组

  • 18岁以下
  • 18至35岁
  • 35岁至50岁
  • 50岁以上

第七章全球减重和肥胖管理市场：依设备分类

  • 心血管训练设备
  • 健身器材
  • 肌力训练器材
  • 手术器械
  • 其他设备

第八章全球减重和肥胖管理市场：依服务分类

  • 咨询服务
  • 瘦身中心
  • 健身中心
  • 网路减重计画
  • 其他服务

第九章全球减重和肥胖管理市场：按分销管道

  • 零售
  • 医药店
  • 大卖场/超级市场
  • 其他分销管道

第十章全球减重与肥胖管理市场：依最终用户分类

  • 医院
  • 门诊手术中心
  • 减重诊所
  • 其他最终用户

第十一章全球减重和肥胖管理市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第十二章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章 公司概况

  • Allergan Plc
  • Allurion Technologies Inc
  • Amgen Inc
  • Apollo Endosurgery, Inc
  • Aspire Bariatrics
  • Eisai Co., Ltd
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Herbalife International of America, Inc
  • Medtronic
  • Novo Nordisk A/S
  • ReShape Lifesciences, Inc
  • Rhythm Pharmaceuticals, Inc
  • Takeda Pharmaceutical Company Limited
Product Code: SMRC25702

According to Stratistics MRC, the Global Weight Loss and Obesity Management Market is accounted for $282.9 billion in 2023 and is expected to reach $554.9 billion by 2030 growing at a CAGR of 10.1% during the forecast period. Technologies and drugs that assist obese or overweight people in losing weight or maintaining their weight are included in the weight loss and obesity management market. Fundamentally, obesity is a long-term medical condition characterized by abnormal fat deposition and accumulation in the body. The Body Mass Index, or BMI, is used to compute it. Some of the methods used to address weight loss and obesity include medications, exercise, nutritional supplements, and weight reduction surgery.

According to a report published by Trust for America's Health, a health policy organization, in 2021, the nation's obesity crisis found that 19 states have obesity rates over 35 percent in U.S.

Market Dynamics:

Driver:

Increasing obesity rates

With a surge in sedentary lifestyles, unhealthy dietary habits, and environmental factors conducive to weight gain, the prevalence of obesity has reached alarming levels. As individuals become increasingly aware of the health risks associated with obesity, including cardiovascular diseases, diabetes, and certain types of cancer, there is a growing demand for effective weight management solutions. This demand fuels the development and adoption of various interventions, ranging from lifestyle modification programs to pharmaceuticals and surgical procedures.

Restraint:

High costs

The expenses associated with weight loss programs, including medications, surgery, counseling, and specialized diets, can pose a barrier to individuals seeking help, particularly those with lower incomes or inadequate health insurance coverage. The financial burden of these interventions often deters individuals from pursuing professional assistance or adhering to prescribed treatment plans. However, the lack of comprehensive insurance coverage for weight loss services further exacerbates the issue, leaving many individuals unable to afford essential treatments. As a result, disparities in access to care widen, perpetuating inequalities in health outcomes related to obesity.

Opportunity:

Technological advancements

Innovative technologies offer diverse solutions, ranging from wearable fitness trackers and mobile applications to advanced surgical techniques and pharmaceutical interventions. These advancements enable personalized and precise strategies for weight loss and obesity management, catering to individual needs and preferences. Digital health platforms provide real-time monitoring, data analysis, and behavior tracking, empowering individuals to make informed decisions about their health and lifestyle choices.

Threat:

Lack of effective long-term solutions

While numerous weight loss interventions exist, sustaining weight loss over the long term remains a significant challenge for many individuals. Fad diets, supplements and temporary lifestyle changes often yield initial results, but they frequently fail to provide lasting benefits. This lack of sustained efficacy undermines consumer confidence and hinders the growth of the market. Moreover, obesity is a complex condition with multifactorial causes, including genetic, environmental, and behavioral factors, making it difficult to develop universally effective treatments.

Covid-19 Impact:

Lockdowns, restrictions on movement, and social distancing measures led to disrupted routines, reduced physical activity, and increased sedentary behavior among populations worldwide. Stress, anxiety, and uncertainty further contributed to unhealthy eating habits and weight gain for many individuals. Conversely, some individuals used the pandemic as an opportunity to prioritize their health and focus on weight loss goals. Telehealth and virtual consultations surged in popularity, enabling remote access to healthcare professionals and weight management programs.

The fitness equipment segment is expected to be the largest during the forecast period

Fitness Equipment segment is expected to hold the largest share during the forecast period. With the rising awareness of the health risks associated with obesity, there's an increasing demand for convenient and effective ways to manage weight. Fitness equipment such as treadmills, stationary bikes, elliptical trainers, and weight lifting machines provide users with versatile options for engaging in physical activity tailored to their preferences and abilities. This accessibility and versatility of fitness equipment empower individuals to take proactive steps towards achieving their weight loss goals, thereby driving growth within the market.

The slimming centers segment is expected to have the highest CAGR during the forecast period

Slimming Centers segment is positioned to witness the profitable growth throughout the overcast period as it offers personalized, comprehensive programs tailored to individual needs, including diet plans, exercise routines, and often, medical supervision. With rising awareness about health and fitness, coupled with the increasing prevalence of obesity, more people are turning to slimming centers for professional guidance and support in achieving their weight loss goals.

Region with largest share:

Asia Pacific region dominated the largest share of the market throughout the estimated period. As awareness grows regarding the adverse effects of obesity on health, individuals are seeking tailored solutions that cater to their specific needs and circumstances. Personalized healthcare approaches, such as genetic testing, customized diet plans, and targeted exercise regimens, are gaining traction as they offer more effective and sustainable results compared to generic treatments. Moreover, wearable fitness devices and mobile health apps, empower individuals to monitor their progress and make informed decisions about their health journey.

Region with highest CAGR:

Europe region is poised to hold lucrative growth over the projection period. As individuals in these regions attain higher levels of income, they tend to prioritize health and wellness, including efforts to manage weight and combat obesity. This burgeoning demand has had a notable impact on the European market for weight loss and obesity management products and services. European companies in this sector are capitalizing on the opportunity by expanding their operations and distribution networks to cater to the growing demand from developing countries. As a result, these elements are boosting the regional growth.

Key players in the market

Some of the key players in Weight Loss and Obesity Management market include Allergan Plc, Allurion Technologies Inc, Amgen Inc, Apollo Endosurgery, Inc, Aspire Bariatrics, Eisai Co., Ltd, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Herbalife International of America, Inc, Medtronic, Novo Nordisk A/S, ReShape Lifesciences, Inc, Rhythm Pharmaceuticals, Inc and Takeda Pharmaceutical Company Limited.

Key Developments:

In March 2023, PRISTYN CARE, a healthcare service provider, announced that it has entered into a strategic partnership with Allurion, a company developing a medical device for weight loss, in order to offer a weight-loss and obesity care platform.

In December 2022, Amgen Inc., announced new Phase 1 data from AMG 133, a novel bispecific glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist and glucagon-like peptide-1 (GLP-1) receptor agonist molecule. This first-in-human study was designed to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic effects of AMG 133 in people with obesity and without diabetes.

Product Types Covered:

  • Drugs
  • Devices
  • Other Product Types

Age Groups Covered:

  • Under 18 Years
  • 18 To 35 Years
  • 35 To 50 Years
  • Above 50 Years

Equipments Covered:

  • Cardiovascular Training Equipment
  • Fitness Equipment
  • Strength Training Equipment
  • Surgical Equipment
  • Other Equipments

Services Covered:

  • Consulting Services
  • Slimming Centers
  • Fitness Centers
  • Online Weight Loss Programs
  • Other Services

Distribution Channels Covered:

  • Retail Sales
  • Pharmaceutical Stores
  • Hypermarket/ Supermarket
  • Other Distribution Channels

End Users Covered:

  • Hospitals
  • Ambulatory Surgery Centres
  • Weight Loss Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Weight Loss and Obesity Management Market, By Product Type

  • 5.1 Introduction
  • 5.2 Drugs
    • 5.2.1 Combination Drugs
    • 5.2.2 Serotonin Receptor Agonists
    • 5.2.3 Lipase Inhibitors
    • 5.2.4 GLP-1 Receptor Agonists
    • 5.2.5 Centrally Acting Drugs
    • 5.2.6 Other Drugs
  • 5.3 Devices
    • 5.3.1 Gastric Electrical Stimulation Systems
    • 5.3.2 Gastric Emptying Systems
    • 5.3.3 Gastric Balloon Systems
    • 5.3.4 Gastric Bands
    • 5.3.5 Bariatric Stapling Devices
    • 5.3.6 Other Devices
  • 5.4 Other Product Types

6 Global Weight Loss and Obesity Management Market, By Age Group

  • 6.1 Introduction
  • 6.2 Under 18 Years
  • 6.3 18 To 35 Years
  • 6.4 35 To 50 Years
  • 6.5 Above 50 Years

7 Global Weight Loss and Obesity Management Market, By Equipment

  • 7.1 Introduction
  • 7.2 Cardiovascular Training Equipment
  • 7.3 Fitness Equipment
  • 7.4 Strength Training Equipment
  • 7.5 Surgical Equipment
  • 7.6 Other Equipments

8 Global Weight Loss and Obesity Management Market, By Service

  • 8.1 Introduction
  • 8.2 Consulting Services
  • 8.3 Slimming Centers
  • 8.4 Fitness Centers
  • 8.5 Online Weight Loss Programs
  • 8.6 Other Services

9 Global Weight Loss and Obesity Management Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Retail Sales
  • 9.3 Pharmaceutical Stores
  • 9.4 Hypermarket/ Supermarket
  • 9.5 Other Distribution Channels

10 Global Weight Loss and Obesity Management Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Ambulatory Surgery Centres
  • 10.4 Weight Loss Clinics
  • 10.5 Other End Users

11 Global Weight Loss and Obesity Management Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Allergan Plc
  • 13.2 Allurion Technologies Inc
  • 13.3 Amgen Inc
  • 13.4 Apollo Endosurgery, Inc
  • 13.5 Aspire Bariatrics
  • 13.6 Eisai Co., Ltd
  • 13.7 F. Hoffmann-La Roche Ltd
  • 13.8 GlaxoSmithKline plc
  • 13.9 Herbalife International of America, Inc
  • 13.10 Medtronic
  • 13.11 Novo Nordisk A/S
  • 13.12 ReShape Lifesciences, Inc
  • 13.13 Rhythm Pharmaceuticals, Inc
  • 13.14 Takeda Pharmaceutical Company Limited

List of Tables

  • Table 1 Global Weight Loss and Obesity Management Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Weight Loss and Obesity Management Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Weight Loss and Obesity Management Market Outlook, By Drugs (2021-2030) ($MN)
  • Table 4 Global Weight Loss and Obesity Management Market Outlook, By Combination Drugs (2021-2030) ($MN)
  • Table 5 Global Weight Loss and Obesity Management Market Outlook, By Serotonin Receptor Agonists (2021-2030) ($MN)
  • Table 6 Global Weight Loss and Obesity Management Market Outlook, By Lipase Inhibitors (2021-2030) ($MN)
  • Table 7 Global Weight Loss and Obesity Management Market Outlook, By GLP-1 Receptor Agonists (2021-2030) ($MN)
  • Table 8 Global Weight Loss and Obesity Management Market Outlook, By Centrally Acting Drugs (2021-2030) ($MN)
  • Table 9 Global Weight Loss and Obesity Management Market Outlook, By Other Drugs (2021-2030) ($MN)
  • Table 10 Global Weight Loss and Obesity Management Market Outlook, By Devices (2021-2030) ($MN)
  • Table 11 Global Weight Loss and Obesity Management Market Outlook, By Gastric Electrical Stimulation Systems (2021-2030) ($MN)
  • Table 12 Global Weight Loss and Obesity Management Market Outlook, By Gastric Emptying Systems (2021-2030) ($MN)
  • Table 13 Global Weight Loss and Obesity Management Market Outlook, By Gastric Balloon Systems (2021-2030) ($MN)
  • Table 14 Global Weight Loss and Obesity Management Market Outlook, By Gastric Bands (2021-2030) ($MN)
  • Table 15 Global Weight Loss and Obesity Management Market Outlook, By Bariatric Stapling Devices (2021-2030) ($MN)
  • Table 16 Global Weight Loss and Obesity Management Market Outlook, By Other Devices (2021-2030) ($MN)
  • Table 17 Global Weight Loss and Obesity Management Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 18 Global Weight Loss and Obesity Management Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 19 Global Weight Loss and Obesity Management Market Outlook, By Under 18 Years (2021-2030) ($MN)
  • Table 20 Global Weight Loss and Obesity Management Market Outlook, By 18 To 35 Years (2021-2030) ($MN)
  • Table 21 Global Weight Loss and Obesity Management Market Outlook, By 35 To 50 Years (2021-2030) ($MN)
  • Table 22 Global Weight Loss and Obesity Management Market Outlook, By Above 50 Years (2021-2030) ($MN)
  • Table 23 Global Weight Loss and Obesity Management Market Outlook, By Equipment (2021-2030) ($MN)
  • Table 24 Global Weight Loss and Obesity Management Market Outlook, By Cardiovascular Training Equipment (2021-2030) ($MN)
  • Table 25 Global Weight Loss and Obesity Management Market Outlook, By Fitness Equipment (2021-2030) ($MN)
  • Table 26 Global Weight Loss and Obesity Management Market Outlook, By Strength Training Equipment (2021-2030) ($MN)
  • Table 27 Global Weight Loss and Obesity Management Market Outlook, By Surgical Equipment (2021-2030) ($MN)
  • Table 28 Global Weight Loss and Obesity Management Market Outlook, By Other Equipments (2021-2030) ($MN)
  • Table 29 Global Weight Loss and Obesity Management Market Outlook, By Service (2021-2030) ($MN)
  • Table 30 Global Weight Loss and Obesity Management Market Outlook, By Consulting Services (2021-2030) ($MN)
  • Table 31 Global Weight Loss and Obesity Management Market Outlook, By Slimming Centers (2021-2030) ($MN)
  • Table 32 Global Weight Loss and Obesity Management Market Outlook, By Fitness Centers (2021-2030) ($MN)
  • Table 33 Global Weight Loss and Obesity Management Market Outlook, By Online Weight Loss Programs (2021-2030) ($MN)
  • Table 34 Global Weight Loss and Obesity Management Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 35 Global Weight Loss and Obesity Management Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 36 Global Weight Loss and Obesity Management Market Outlook, By Retail Sales (2021-2030) ($MN)
  • Table 37 Global Weight Loss and Obesity Management Market Outlook, By Pharmaceutical Stores (2021-2030) ($MN)
  • Table 38 Global Weight Loss and Obesity Management Market Outlook, By Hypermarket/ Supermarket (2021-2030) ($MN)
  • Table 39 Global Weight Loss and Obesity Management Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 40 Global Weight Loss and Obesity Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 41 Global Weight Loss and Obesity Management Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 42 Global Weight Loss and Obesity Management Market Outlook, By Ambulatory Surgery Centres (2021-2030) ($MN)
  • Table 43 Global Weight Loss and Obesity Management Market Outlook, By Weight Loss Clinics (2021-2030) ($MN)
  • Table 44 Global Weight Loss and Obesity Management Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.